Discover
SNSE
Sensei Biotherapeutics, Inc.
13.85
2 x 11.49
2 x 17.76
bid
ask
-
3.97
22.28%
04:00 PM
| Ytd | 29.80% | |
| 1y | 85.16% |
13.76
day range
16.52
6.33
52 week range
36.76
| Open | 15.21 | Prev Close | 17.82 | Low | 13.76 | High | 16.52 | Mkt Cap | 18.59M |
| Vol | 219.47K | Avg Vol | 52.33K | EPS | -142.72 | P/E | -0.10 | Forward P/E | -0.40 |
| Beta | -0.25 | Short Ratio | 0.29 | Inst. Own | 8.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 21.49 | 200-d Avg | 16.71 | 1yr Est | 4.13 |
| Income Statement | |||
| Operating Expenses | 170.63M | ||
| Research and Development Expense | 17.96M | ||
| Selling, General and Administrative Expense | 19.71M | ||
| Operating Income | -170.63M | ||
| Net Income | -170.24M | ||
| Net Income Common Stock | -170.24M | ||
| Net Income Common Stock (USD) | -170.24M | ||
| Consolidated Income | -170.24M | ||
| Earnings per Basic Share | -131.45 | ||
| Earnings per Basic Share (USD) | -131.45 | ||
| Earnings per Diluted Share | -131.45 | ||
| Earning Before Interest & Taxes (EBIT) | -170.24M | ||
| Earning Before Interest & Taxes (USD) | -170.24M | ||
| Weighted Average Shares | 1.30M | ||
| Weighted Average Shares Diluted | 1.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 152.32M | ||
| Cash and Equivalents (USD) | 152.32M | ||
| Investments | 50.47M | ||
| Investments Current | 50.47M | ||
| Current Assets | 204.23M | ||
| Property, Plant & Equipment Net | 982.00K | ||
| Total Assets | 205.38M | ||
| Debt Current | 1.04M | ||
| Total Debt | 1.04M | ||
| Current Liabilities | 14.19M | ||
| Total Liabilities | 14.19M | ||
| Accumulated Retained Earnings (Deficit) | -453.37M | ||
| Accumulated Other Comprehensive Income | -24.00K | ||
| Shareholders Equity | -137.29M | ||
| Shareholders Equity (USD) | -137.29M | ||
| Assets Non-Current | 1.15M | ||
| Total Debt (USD) | 1.04M | ||
| Liabilities Non-Current | 1000 | ||
| Trade and Non-Trade Payables | 8.98M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 411.00K | ||
| Net Cash Flow from Financing | 185.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 143.66M | ||
| Capital Expenditure | -6.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 6.46M | ||
| Issuance (Purchase) of Equity Shares | -14.11M | ||
| Issuance (Repayment) of Debt Securities | -62.00K | ||
| Net Cash Flow from Investing | -31.44M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -37.89M | ||
| Net Cash Flow from Operations | -10.73M | ||
| Share Based Compensation | 12.90M | ||